Epidermoid carcinoma is the utmost frequent type of skin
cancer
worldwide resulting in bacterial infection-induced chronic wounds.
The primary available treatment option is surgery and subsequent skin
transplantation, which is challenging in terms of associated pain,
full cure, skin regeneration, and cost. Combinatorial chemo-phototherapy
involving photodynamic therapy and chemotherapy can be a potential
treatment for skin cancers and associated chronic wounds. Herein,
we devised a multidrug-loaded nanoformulation (RB@CPT-LNPs) by encapsulating
Camptothecin (CPT, a chemotherapeutic agent) into biocompatible lignin
nanoparticles (LNPs), followed by surface conjugation with Rose Bengal
(RB, a photosensitizer). The RB@CPT-LNPs were found to be highly stable
(polydispersity, <0.3) in an aqueous solution with size and Zeta
potential 170 nm and −14.7 mV, respectively. The RB@CPT-LNPs
showed efficient reactive oxygen species generation (ΦΔ, 0.74) in vitro when activated by light. Importantly,
RB@CPT-LNPs showed augmented anticancer activity in skin cancer cells
(A431) upon 525 nm laser irradiation compared with a single treatment
(photodynamic therapy or chemotherapy). Further, the formulation also
showed high photodynamic antimicrobial activity against both Gram-positive
and Gram-negative bacteria. Therefore, the developed RB@CPT-LNP formulation
could offer an effective strategy for the elimination of skin cancer
and skin-tumor-induced chronic wounds.